Literature DB >> 30786259

Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer's disease.

Kenyu Hayashi1, Yu Hasegawa2, Yushin Takemoto1, Cheng Cao1, Hiroto Takeya3, Yoshihiro Komohara3, Akitake Mukasa4, Shokei Kim-Mitsuyama1.   

Abstract

Systemic organ dysfunction is one of the important issues for the patients with Alzheimer's disease (AD) and their caregivers. Recent evidences suggest that periodontitis is a possible risk factor for progression of AD and lipopolysaccharide derived from Porphyromonas gingivalis (Pg-LPS) which is a major periodontopathic bacteria induces cognitive impairment in mice. However, the precise relationships between the brain exposure of Pg-LPS and systemic organ dysfunction in AD patients are still undetermined. In this study, we investigated whether brain exposure of Pg-LPS induced systemic organ dysfunction in a model of AD mouse. We employed 6 (young) and 13 (middle-aged) months-old 5XFAD mice and 6 months-old littermate (LT) mice, and treated with intracerebroventricular (ICV) injection of 2 μg Pg-LPS or saline (vehicle). The animals were monitored cognitive functions (Y maze, nest building, and Morris water maze tests), motor functions (wire hang and rotarod tests), physical condition (symptom score), and blood pressure (BP). Twenty-eight days later, their organs were weighted and the organ damages were examined. Continuous ICV injection of 2 μg/day Pg-LPS increased ionized calcium binding adapter molecule-1 (Iba-1) and cluster of differentiation 3 (CD3) positive cells in periventricular area of 5XFAD mice without enhancement of cognitive impairment, amyloid β protein deposition, expressions of phosphorylated nuclear factor-kappa B (NF-κB) and cyclooxygenase-2 (COX-2). In addition, the Pg-LPS lowered the latency of rotarod test in young 5XAD mice and also reduced symptom score and weight of gastrocnemius muscle in the middle-aged animals. Moreover, the Pg-LPS induced cardiac atrophy in both young and middle-aged 5XFAD mice, and increased Iba-1 positive cells in left ventricle of the young animals. On the other hand, single ICV injection of 2 μg Pg-LPS in 5XFAD and continuous injection of 2 μg/day Pg-LPS in LT mice did not show any positive findings. Our present results demonstrated that continuous brain exposure of Pg-LPS started sarcopenia and cardiac injury without enhancing cognitive impairment in AD model mice.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Brain exposure; Cardiac injury; Lipopolysaccharide; Porphyromonas gingivalis; Sarcopenia

Year:  2019        PMID: 30786259     DOI: 10.1016/j.exger.2019.02.007

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  12 in total

1.  miR-671-5p Attenuates Neuroinflammation via Suppressing NF-κB Expression in an Acute Ischemic Stroke Model.

Authors:  Ling Deng; Yi Guo; Jingdong Liu; Xuan Wang; Sha Chen; Qian Wang; Jianyan Rao; Yuchun Wang; Tianrui Zuo; Qingwen Hu; Xiahong Zhao; Zhi Dong
Journal:  Neurochem Res       Date:  2021-04-19       Impact factor: 3.996

Review 2.  Relationship of Porphyromonas gingivalis and Alzheimer's disease: a systematic review of pre-clinical studies.

Authors:  Moan Jéfter Fernandes Costa; Isabela Dantas Torres de Araújo; Luana da Rocha Alves; Romerito Lins da Silva; Patricia Dos Santos Calderon; Boniek Castillo Dutra Borges; Ana Rafaela Luz de Aquino Martins; Bruno Cesar de Vasconcelos Gurgel; Ruthineia Diogenes Alves Uchoa Lins
Journal:  Clin Oral Investig       Date:  2021-01-20       Impact factor: 3.573

3.  Long Non-coding RNA ANRIL Downregulation Alleviates Neuroinflammation in an Ischemia Stroke Model via Modulation of the miR-671-5p/NF-κB Pathway.

Authors:  Ling Deng; Jin Jiang; Sha Chen; Xing Lin; Tianrui Zuo; Qingwen Hu; Yu Wu; Xiaomei Fan; Zhi Dong
Journal:  Neurochem Res       Date:  2022-03-31       Impact factor: 3.996

Review 4.  Porphyromonas gingivalis outside the oral cavity.

Authors:  Steeve Bregaint; Emile Boyer; Shao Bing Fong; Vincent Meuric; Martine Bonnaure-Mallet; Anne Jolivet-Gougeon
Journal:  Odontology       Date:  2021-08-19       Impact factor: 2.634

5.  The optimization of ligature/bone defect-induced periodontitis model in rats.

Authors:  Jingyi Gao; Simin Cai; Zijie Wang; Dan Li; Minyi Ou; Xinlu Zhang; Zhihui Tian
Journal:  Odontology       Date:  2022-06-03       Impact factor: 2.885

6.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

Review 7.  Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease.

Authors:  Rosalia Marcano; M Ángeles Rojo; Damián Cordoba-Diaz; Manuel Garrosa
Journal:  Toxins (Basel)       Date:  2021-07-29       Impact factor: 4.546

8.  Expression Profiling and Cell Type Classification Analysis in Periodontitis Reveal Dysregulation of Multiple lncRNAs in Plasma Cells.

Authors:  Donglei Wu; Peng Zhou; Fengdi Cao; Zhengshen Lin; Defeng Liang; Xincai Zhou
Journal:  Front Genet       Date:  2020-04-28       Impact factor: 4.599

9.  Alzheimer's Disease-Like Pathology Triggered by Porphyromonas gingivalis in Wild Type Rats Is Serotype Dependent.

Authors:  Jaime Díaz-Zúñiga; Jamileth More; Samanta Melgar-Rodríguez; Matías Jiménez-Unión; Francisca Villalobos-Orchard; Constanza Muñoz-Manríquez; Gustavo Monasterio; José Luis Valdés; Rolando Vernal; Andrea Paula-Lima
Journal:  Front Immunol       Date:  2020-11-09       Impact factor: 7.561

Review 10.  The Impact of Systemic Inflammation on Alzheimer's Disease Pathology.

Authors:  Junhua Xie; Lien Van Hoecke; Roosmarijn E Vandenbroucke
Journal:  Front Immunol       Date:  2022-01-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.